Sumitovant Biopharma Ltd., 10% Owner at Myovant Sciences Ltd. (MYOV), bought 100,000 shares at $12.08 ($1.2M) on 2020-04-30, disclosed to the SEC on 2020-05-01.
Open-market purchase of $1.2M MYOV by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $11.92 | 50,000 | $596K | 49.7% |
| 2 | $12.08 | 50,000 | $604K | 50.3% |
| Total | $12.00 avg | 100,000 | $1.2M | 100% |
| Filing → |
| MYOV | BUY | 2021-09-16 | $7.1M | — | Filing → |
| MYOV | BUY | 2021-09-08 | $3.4M | — | Filing → |
| MYOV | BUY | 2021-08-26 | $2.8M | — | Filing → |